Home › News › Clinical Trials › Archive

Clinical Trial News Archive

Get news By email or subscribe to our News feeds.

All News Consumer Pharma New Drugs Pipeline Clinical Trials

November 2008

November 3

CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma Antiangiogenic Role of 2ME2 Demonstrated in Rheumatoid Arthritis Models Medarex and Massachusetts Biologic Laboratories Announce Primary Objective Achieved in Phase 2 Trial of Monoclonal Antibody Combination for the Treatment of Clostridium difficile Associated Diarrhea (CDAD) Oncolytics Biotech Inc. Collaborators Present Positive Combination and Docetaxel Results at iSBTc Annual Meeting Oncolytics Biotech Inc. Collaborators Present Positive Phase I/II Combination Reolysin and Paclitaxel/Carboplatin Results at iSBTc Annual Meeting CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma Cell Therapeutics Announces Study Data Set Cut-off for Phase III Pivotal Pixantrone (301) Trial Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients Romark Announces Presentation of New Data for Nitazoxanide in Chronic Hepatitis C at AASLD 2008 Gilead Announces Two-Year Data from Pivotal Phase III Studies Evaluating Viread(R) for Chronic Hepatitis B GlobeImmune Hepatitis C Therapeutic Vaccine, GI-5005 Study Suggests Treatment with Paliperidone ER Significantly Improves Symptoms of Schizoaffective Disorder Avineuro Announced Advancing Potent Small Molecule for Treatment of Alzheimer's Disease to Clinical Development New Study Demonstrated Actemra (tocilizumab) Inhibited Progression of Joint Damage in Rheumatoid Arthritis Patients Top-Line Preliminary Data From Phase II/III Study of Corthera's Relaxin in Acute Heart Failure to be Presented in Satellite Symposium at AHA Scientific Sessions 2008 Medgenics Announces Encouraging Preliminary Data For Phase I/II Clinical Trial of EPODURE In Renal Anemia New Clinical Data Support Broad Profile for Telaprevir in Patients with Genotype 1 Hepatitis C Virus (HCV) Infection Anti-VEGF Drugs for Retinal Diseases Could Have Serious Side Effects, Scientists Caution Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers Durezol in the Treatment of Uveitis and Ganciclovir in the Treatment of Herpetic Keratitis: Studies of Treatments for Leading Causes of Blindness to Be Presented PAREXEL Expert to Address Key Aspects of Conducting Clinical Trials in China at 7th Annual Partnerships in Clinical Trials Congress New Data Suggest Long-Term Treatment with Baraclude (entecavir) May Reduce Liver Damage Caused by Chronic Hepatitis B

November 4

NicOx announces favorable blood pressure data for naproxcinod in a large ABPM study Phase IIa data on TMC435350 in patients with hepatitis C now presented at the ongoing AASLD ZymoGenetics Presents Positive Interim Phase 1b Results in Hepatitis C Vertex announces positive data at the annual AASLD meeting YM Biosciences Reports Data From Exploratory Clinical Trials Of Nimotuzumab In Brain Metastases And High-Grade Glioma Presented At 2008 Eortc-Nci-Aacr Annual Meeting Oramed Pharmaceuticals Chosen to Present Results of GLP-1 Analog Enteral Administration Study at the Diabetes Technology Society's Eighth Annual Meeting (November 13-15, 2008; Bethesda, Maryland) AMA Journal Publishes Study Showing Evidence of a Major Environmental Trigger For Autism Micromet Presents Data at the 23rd Annual Meeting of the International Society for Biological Therapy of Cancer on the Activity of Human Antibody Adecatumumab against KRAS-mutated Colon Cancer Cells PRA International Addresses Sponsor-CRO Partnering Strategies at European Partnerships in Clinical Trials Congress Generex Oral-lyn Featured at International Diabetes Conference Premier Research Achieves Double-Digit Growth in Functional Sourcing for the Third Straight Year NicOx Announces Favorable Blood Pressure Data for Naproxcinod in a Large ABPM Study

November 5

Kendle Reports Record 3Q 08 Net Income and Total Business Authorizations Ambrx to Present Phase I/II Clinical Data for Optimized, Long Acting Human Growth Hormone Analogue SciClone and Sigma-Tau Report Phase 3 Hepatitis C Trial Results AgilityBio and Advinus Announce Partnership to Introduce Digital Pathology Services in Pre Clinical Research Centre Hospitalier Universitaire Vaudois, Swiss Vaccine Research Institute and Institut Genetique Moleculaire Montpellier: Study Sheds Light on the Mechanisms of Increased Risk of HIV Infection in the Step HIV Vaccine Trial Five Synexus Sites Randomise More Than 1300 Patients in Three Weeks Bio-Imaging Technologies Announces Third Quarter 2008 Financial Results Zannos Grekos, MD to Present Clinical Results of Regenerative Stem Cell Treatments to the Dubai Congress on Anti-Aging and Aesthetic Medicine

November 6

PAREXEL Expands Pioneering Asian Ethnobridging Expertise Bavarian Nordic reports successful safety data from Phase II study with Imvamune Azilect Shown to Be a Selective MAO-B Inhibitor Canopus BioPharma Announces Positive Results in Human Study of Novel Peptide Cancer Vaccine Living Cell Technologies Reports on 12-Month Clinical Effects of DiabeCell at Annual General Meeting Dendreon Presents Integrated Analysis of Clinical Data from Neuvenge Trials at Chemotherapy Foundation Symposium Portola Announces Data Presentations Relevant to Its Lead Phase II Antithrombotic Compounds at American Heart Association Scientific Sessions 2008 Webcast Alert: Isis Pharmaceuticals' Cardiovascular Program Review Data to Be Presented at 58th Annual Meeting of The American Society of Human Genetics Aegerion Pharmaceuticals, Inc. Announces AEGR-733 Phase II Data Demonstrates Significant Lowering of LDL Cholesterol with Promising Hepatic Safety Profile Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium VIA Pharmaceuticals Announces Conference Call and Webcast to Discuss VIA-2291 Phase 2 Data Presentations at AHA Proteon Therapeutics Presents New Data on PRT-201 at the Annual Meeting of the American Society of Nephrology in Philadelphia Pervasis Therapeutics Presents Safety Data from Phase 1 and 2 Clinical Trials of Vascugel at the American Society of Nephrology Annual Meeting Morria Biopharmaceuticals Plc Announces Positive Clinical Results for MRX-4 in its Phase II Clinical Study in Allergic Rhinitis Patients Affymax Announces New Data Presented on the Long-Term Safety and Effectiveness of Hematide to Treat Anemia in Chronic Renal Failure Patients with Monthly Dosing Acologix Presents Findings From the UREMIC PRURITIS National Registry Study at the 41st Annual Meeting of the American Society of Nephrology Poniard Pharmaceuticals Announces Final Top-Line Results from Phase 1 Trial Demonstrating Positive Bioavailability with Oral Picoplatin Oncolytics Biotech Inc. Investigators Present Interim U.S. Reolysin Phase II Sarcoma Trial Data Cytochroma Announces Positive Comparative Data on CTA018 in Chronic Kidney Disease Model Study From the University of Texas M.D. Anderson Cancer Center Demonstrates That AHC is Safe in Combination With Most Chemotherapeutic Agents DW Healthcare Partners Forms Best in Class Organization with ClinPro Inc. and Pacific Data Designs, LLC LSR Announces Third Quarter Results

November 7

Full Results of Varisolve US Phase II Safety Study to be Presented at ACP Phase III Study (SATURN) Showed Tarceva Improved Progression-Free Survival as a First-Line Maintenance Therapy for Advanced Non-Small Cell Lung Cancer Cytochroma Announces Positive Comparative Data on CTA018 Kendle Named a 'Best Place to Work' in Greater Cincinnati Sciele Pharma and Plethora Solutions Announce Positive Phase III Clinical Results of PSD502 for Premature Ejaculation Acologix AC-200 Demonstrates Positive Effect on Bone in Preclinical Model of Chronic Kidney Disease Pervasis Therapeutics Presents Data at American Society of Nephrology Meeting Atrial Fibrillation Found to be Common in Patients With Atherothrombosis, Increases Risk of Cardiovascular Death, Heart Attack and Stroke Theratechnologies Presents Additional Results from its Tesamorelin Phase 3 Studies at the 10th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV Rationale and Design of CURRENT-OASIS 7 Study Published in American Heart Journal Data From Investigational Use of Procrit (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting iCo Therapeutics Oral Amphotericin B Effective Against Visceral Leishmaniasis Santhera Presents Preclinical Data on Oral MC4 Receptor Antagonists for Treatment of Cancer Cachexia at AICR Research Conference

November 10

Aradigm Completes Study of Inhaled Treprostinil with AERx Inhaler Memory Pharmaceuticals Announces Six Abstracts Accepted for Presentation at Society for Neuroscience Meeting Zevalin Following Short-Course Chemotherapy with CHOP + Rituximab (CHOP-R) Doubles Complete Remission Rate in First-Line Treatment of Follicular Non- Hodgkin's Lymphoma EKC-Cide Study Results Presented at National Ophthalmology Meeting Geron Scientists and Collaborators Demonstrate TAT2 - A Small Molecule Telomerase Activator - Enhances Antiviral Function of Immune Cells From HIV+ Donors VIA Pharmaceuticals Announces Positive Results of Phase 2 Studies of VIA-2291 in Patients With Serious Cardiovascular Disease First-Ever Study Conducted Demonstrating Economic, Individual, and Societal Burden of Hereditary Angioedema EntreMed's MKC-1 Meets Primary Efficacy Endpoint in Non-Small Cell Lung Cancer Clinical Trial Molecular Insight Pharmaceuticals, Inc. To Present Results from a Prospective Analysis of Zemiva Phase 2b Data at the 2008 Scientific Sessions of the American Heart Association Study Showed Prevention of Heart Attacks Within Three Months After Hospitalization Significantly Averted Future Heart Attacks and Death ProtoKinetix Receives Independent Confirmation of AAGP Anti-Inflammatory Action Study Shows Potential Benefits of Xolair in Treating Children Suffering from Moderate or Severe Persistent Allergic Asthma Inadequately Controlled With Inhaled Corticosteroids Glaucoma Research and Patient Care Highlighted at American Academy of Ophthalmology Meeting New Analysis Shows Troubling Trend in Triglyceride Levels May Be Linked to Rising Rates of Obesity Celladon Announces Presentation of Clinical Data From First-in-Human Mydicar Trial for Advanced Heart Failure at American Heart Association Scientific Sessions The Results From a Clinical Trial Led by the Montreal Heart Institute Demonstrate That Drug Reduces Inflammation in Patients With Serious Cardiovascular Disease UCLA Medical Researchers Report Brain Injury After Cardiac Arrest May Be Avoided Crestor Demonstrates Dramatic CV Risk Reduction in a Large Statin Outcomes Study Results of Studies of Alvesco for the Treatment of Asthma and Omnaris in an HFA Nasal Aerosol Presented at American College of Allergy, Asthma & Immunology Annual Meeting Molecular Insight Announces Positive Results from a Prospective Analysis of Phase 2b Data for Zemiva in Emergency Department Setting Research Identifies Predictors for Successful IVF Interim Analysis of Top-Line Data From Phase II/III Study Shows Favorable Efficacy & Safety for Corthera's Relaxin in Acute Heart Failure Keryx Biopharmaceuticals' KRX-0401 (Perifosine) Data Selected for Oral Presentation at the 50th Annual Meeting of the American Society of Hematology Rivaroxaban Phase II Dose-Ranging Study Demonstrates Encouraging Response Rates in Treatment of Acute Coronary Syndrome Patients Largest Study Demonstrates Comparable Pregnancy Outcomes Using Vaginal Gel versus Injectable Progesterone, with Frozen Embryos from Donor Eggs Santaris Pharma Releases Positive Data on LNA-based Survivin Inhibitor Four Pralatrexate (PDX) Studies to Be Presented at the 50th Annual Meeting of the American Society of Hematology Potentia Pharmaceuticals' Drug Candidate for Age-Related Macular Degeneration Shows Positive Safety Profile in Phase I Clinical Trial Genmab A/S: Ofatumumab Pivotal CLL Data to be Presented at ASH RVX-208 Exploratory Study Illustrates Early Potential for Alzheimer's Disease Ofatumumab Pivotal CLL Data to be Presented at ASH

November 11

Intestinal Infection Afflicts 13 of 1,000 Hospital Patients, Infection Rates 6.5 - 20 Times Greater Than Previous Estimates, New Study Says RVX-208 Data Demonstrates Increase in Functional HDL Particles Researchers to Present Additional Data on Soliris (eculizumab) for the Treatment of PNH at the ASH Annual Meeting Cell Therapeutics' Pixantrone Phase III (EXTEND) Pivotal Trial Successful in Achieving Primary Endpoint PARI Pharma Completes Successful Clinical Trials for Tobramycin 100 & Investigational eFlow for CF NEI Releases Complete Data From Age-Related Eye Disease Study FibroGen Announces New Research on HIF-PHI and Anti-CTGF Development Programs in Chronic Kidney Disease Sangamo BioSciences Announces Results From Diabetic Neuropathy Clinical Trial SB-509-601 Rigel's R788 Phase 2a Results Published in Arthritis and Rheumatism Potentia Presents Phase I Data on Leading AMD Drug at AAO WomenHeart Urges Women to Talk With Doctors About New Study Showing Statins Prevent Heart Attacks, Deaths Anesiva Announces Adlea ACTIVE-1 Phase 3 Clinical Results, Ceasing of Zingo Commercial Operations and Restructuring CPEX Pharmaceuticals Announces Publication in Journal of Diabetes Science and Technology Optimer Pharmaceuticals Reports Positive Data from its North American Phase 3 CDI Study of OPT-80 Anthera's Varespladib Demonstrates Significant Anti-Inflammatory Effect and LDL Reduction in Patients With Coronary Heart Disease INNO-406 Demonstrates Positive Clinical Responses in Phase 1 Trial in Patients with Chronic Myeloid Leukemia Triglyceride Levels Continue to Rise in the United States Despite Increased Use of Cholesterol-Lowering Medications LCP-AtorFen Phase II Data to Be Presented at the American Heart Association's 2008 Scientific Sessions in New Orleans, LA, on November 11 New Research of Amyloid Cardiomyopathy Fosters Better Understanding of Disease Progression Lipocine Establishes Clinical Feasibility of Once-a-Day Ziprasidone Testosterone Effective in Female Sexual Dysfunction; BioSante Conducting Long-Term Safety Study of LibiGel in FSD IMM, Cenix, and Alnylam Discover New Targets in Malaria Infection with RNAi Technology Published Study Demonstrates Oxycyte Can Improve Cognitive Recovery And Reduce Neuronal Cell Loss After Traumatic Brain Injury in Animal Model Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia Program Colesevelam HCl Lowered LDL Cholesterol in Pediatric Patients With Heterozygous Familial Hypercholesterolemia Drug-Eluting Stents Beat Bare Metal Stents in Diabetics Dronedarone (Multaq) Reduced the Incidence and Duration of Hospitalization in Patients with Atrial Fibrillation Statin Reduces Heart Attack, Stroke Rates in Patients With Normal Cholesterol but Elevated C-Reactive Protein Tailored Drug Delivery Reduces Adverse Effects After PCI Study Finds Timing Is Everything For Some Heart Attack Patients Phase II Trial of Experimental Anti-Coagulant Reports Safety and Outcomes Data Heart Failure Patients With Normal Left Ventricular Ejection Fraction Don't Benefit From Treatment With Angiotensin II Receptor Blocker POZEN'S PA32520 Study Data Demonstrated Better Upper Gastrointestinal Protection Interferon Reduces, Eliminates Viral Infections in Heart Failure Patients MD Biosciences to Showcase Pre-Clinical Capabilities at the Neuroscience 2008 Conference New study: A Common Class of GI Medications Reduce Protection Against Heart Attack in Patients Taking Widely Prescribed Cardiovascular Drug APIC Covers Up Extent and Causes of Deadly C. diff Colesevelam HCl Lowered LDL Cholesterol in Pediatric Patients with Heterozygous Familial Hypercholesterolemia Rasilez, first-in-class direct renin inhibitor, provides greater reduction in high blood pressure than ACE inhibitor ramipril in patients 65 and older Study Demonstrating Lovaza/Omacor Co-administered with Atorvastatin Reduces Non-HDL Cholesterol to be presented at AHA

November 12

Acusphere Announces Data Demonstrating Imagify Perfusion Stress Echo Predicts Presence of Coronary Artery Disease American Academy of Ophthalmology Joint Meeting Marked by Strong Turnout and Rich Scientific Program NicOx' Naproxcinod Shows Highly Significant Reduction in Daytime Blood Pressure Versus Naproxen Titan Pharmaceuticals Announces Data Presentations for Probuphine at the 2008 International Society of Addiction Medicine Congress Pervasis Therapeutics to Present Safety and Efficacy Data from Phase 1 and 2 Clinical Trials of Vascugel(R) at the 35th Annual VEITHsymposium(TM) Metabolex Announces Positive Results From Phase 1a Clinical Trial of MBX-2982 ImmunoCellular Therapeutics Presents Data Demonstrating Immune Response Targeting Cancer Stem Cells SCOLR Pharma, Inc. to Attend American Association of Pharmaceutical Scientists - AAPS - Annual Meeting and Exposition Portola Announces Data Showing Its Anti-Platelet Drug Inhibits Platelets in Clopidogrel (Plavix) Non-Responders New Analysis Suggests That Improvements in Kidney Function in Patients Treated with Lipitor Strongly Correlate with a Reduced Risk of Major Cardiovascular Events Nymox Reports Positive New Results in 59 Week Study of Drug for Enlarged Prostate Tercica Announces Results from Increlex Phase IIIb Study Demonstrating Dose-Dependent Height Velocity Increase in Primary IGFD Short Stature Population and Other Increlex Studies at the 13th International Congress of Endocrinology Meeting Ongoing Pregnancy Rates among Infertility Patients with Luteal Phase Bleeding No Different with Vaginal Gel or Injectable Progesterone Benign or Cancerous? Tibotec Data Presented at ICAAC and HIV9 Follow key Regulatory Approvals for Anti-HIV Compounds Nymox Reports Positive New Results in 59 Week Study of Drug for Enlarged Prostate Long-term study evaluates boosted Prezista vs. lopinavir/ritonavir as part of HIV combination therapy in treatment-naive adults

November 13

MorphoSys Publishes Preclinical Data from MOR103 Program Lexicon's Drug Candidate LX1032 for Carcinoid Syndrome Successfully Completes Phase 1 Clinical Trials Osteoporosis Drugs May Prevent Future Bone Growth Gardasil, Merck's Cervical Cancer Vaccine, Demonstrated Efficacy in Preventing HPV-Related Disease in Males in Phase III Study Avexa Presents Data from Apricitabine and Antibacterial Programs at two International Conferences Micromet to Present Interim Data from Two Studies for T Cell Engaging BiTE Antibody Blinatumomab at American Society of Hematology Annual Meeting Gardasil, Merck's Cervical Cancer Vaccine, Demonstrated Efficacy in Preventing HPV-Related Disease in Males in Phase III Study Clinical Data Show Long-Acting Human Growth Hormone ARX201 is Safe and Well Tolerated Scientists Crack the Code to Tamoxifen Resistance Seniors Can Be Heartened by New Study on Statins Preclinical Study Presented at the International Congress of Endocrinology Shows Intravail Drug Delivery Technology Provides Unmatched Non-Invasive Delivery of an Anti-Obesity Peptide Merck KGaA: Overall Survival in First-Line NSCLC Reaches 15 Months ViroPharma Announces Presentation of Cinryze Data in Acute Treatment of Hereditary Angioedema BioReliance Corporation Announces that Sarah Sheridan, Ph.D. Will Deliver a Poster Presentation at the 16th Annual European Society of Gene and Cell Therapy Conference Avastin Gives an Additional Four Months of Life to Patients with One of the Most Common Types of Lung Cancer

November 17

FREEDOM-C Trial of Oral Treprostinil in Pulmonary Arterial Hypertension Fails to Meet Primary Endpoint Alkermes Presents Positive Preclinical Data on Novel, ProprietaryMolecule Designed to Improve Outcomes for Patients Taking OpioidAnalgesics Medivation Announces Upcoming Data Presentations on Dimebon's Mechanism of Action Paloma Pharmaceuticals Publishing Seminal Paper in Cancer Research and Presentation at the AACR Special Conference in Cancer Research Sequella Presents Data on Synergy Between Investigational New TB Drugs SQ109 and TMC207 Patients Experienced Nearly a 70% Reduction in Pain When Using MPMMedical's Regenecare Wound Care Gel ZIOPHARM Oncology Presents Positive Data from Studies of Palifosfamide Hepatitis C Therapeutic DNA Vaccine Delivered by Inovio Biomedical's Electroporation Technology Reduces Viral Load by Up to 99.7% Biodel Reports Protective Effects of VIAject Insulin on Microvascular Function in Patients with Type 2 Diabetes ARYx Therapeutics Presents Clinical Data for ATI-5923 at American Heart Association Scientific Sessions 2008

November 18

Long-Term TITAN Study Evaluates Prezista/ritonavir vs. lopinavir/ritonavir as Part of HIV Combination Therapy in Treatment-Experienced Adults Cimzia (certolizumab pegol) Studies Show Significant Clinical Benefits for Mono- and Combination Therapy in Patients with Rheumatoid Arthritis Company's MPACs for the Treatment of Alzheimer's Disease Shown to Prevent Neural Cell Death and the Production of Amyloid-Beta Protein Study Published In Archives Of Surgery Demonstrated Benefit Of Entereg (Alvimopan) In Postoperative Ileus Metabolex Announces Positive Results from Phase 2 Clinical Trial of MBX-8025 XTL Biopharmaceuticals Announces Top-Line Results From the Bicifadine Phase 2b Study for Diabetic Neuropathic Pain New Publication Shows Angiomax Significantly Reduces Initial Hospital Costs by $572 Per Patient Compared to Conventional Therapy in Moderateand High-Risk ACS Patients New Data Will Be Presented at ASH on Velcade (Bortezomib) for Injection-Based Therapies in Multiple Myeloma and Non-Hodgkin's Lymphoma Research Provides Further Evidence for the Mechanism of Action Underlying Hythiam’s Prometa Treatment Program Provectus Lead Investigator Professor John F. Thompson to Present at Clinical Oncological Society of Australia 2008 Annual Scientific Meeting on November 19, 2008

November 19

Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting Elixir Pharmaceuticals’ Phase III Trial of Metformin-Mitiglinide Combination Therapy Demonstrates Significant Reductions in HbA1c (Blood Glucose) Levels Compared to Type 2 Diabetes Patients Not Well-Controlled on Metformin Alone GenVec Announces Interim Survival Data in Pivotal Trial of TNFerade in Locally Advanced Pancreatic Cancer Titan Pharmaceuticals Presents Phase 3 Data for Probuphine at the 2008 International Society of Addiction Medicine Congress Jazz Pharmaceuticals Cancels Presentation Planned for November 19, 2008 at Lazard Capital Markets 5th Annual Healthcare Conference Pervasis Therapeutics Announces Promising Efficacy Results from Phase1 and 2 Clinical Trials of Vascugel® in Dialysis Patients Needing Permanent AV Access, Data Builds on Compelling Safety Findings New Study Proves Protandim Produces 300% Increase in Glutathione, a Key Antioxidant and Anti-aging Factor Helix BioPharma Presents Preclinical L-DOS47 Data at The Second Conference of Lung Cancer in Warsaw, Poland Suven Life Sciences Presenting Biology Data of Their NCE’s at Society for Neuroscience Annual Meeting, SFN-2008 at Washington DC, USA Phase III Studies Show That Vandetanib (Zactima) Brings Clinical Benefits to Patients With Lung Cancer Bradmer to Present Poster on Progression Free Survival and Overall Survival Data from Neuradiab Phase II Trials at Society for Neuro-Oncology Meeting Oxford BioMedica Announces Six-Month Efficacy Results With Low Dose of ProSavin in Phase I/II Trial in Parkinson’s Disease Genfit New Phase I Clinical Trials with High-Dose Confirm the Excellent Tolerance of GFT505 in Healthy Volunteers KAI Reports Positive Preclinical Results for KAI-1678, First-in-ClassCompound to Treat Pain Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream

November 20

Lytix Presents LTX-109 Anti-Microbial Data at ICAAC Alnylam Presents Pre-clinical Data from TTR Amyloidosis Development Program Targacept Scientists Make Multiple Presentations at Society for Neuroscience Supporting the Potential of NNR Therapeutics to Treat CNSDiseases and Disorders Provectus Lead Investigator Professor John F. Thompson Gives Update on PV-10 Melanoma Study at Clinical Oncological Society of Australia 2008 Annual Scientific Meeting Gloucester Pharmaceuticals to Present Positive Results from Multiple Romidepsin Clinical Trials at the ASH Annual Meeting Thought Leaders from Burzynski Research Institute, Inc. Present Encouraging Data on Antineoplastons for Treatment of Malignant Gliomas Biovitrum and Symphogen Report Positive Clinical Results in Novel Rh-immunization Prevention Project Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology

November 21

Rexin-G Controls Tumor Growth and Improves Survival in Chemotherapy-Resistant Soft Tissue Sarcoma and Osteosarcoma: Phase I/II & Confirmatory Phase II Studies Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia New Study Data: Januvia (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes Burzynski Research Institute, Inc. (BRI) Presents Promising Phase II Data on Malignant Glioma Iressa Proves Just as Effective as Chemotherapy for Lung Cancer Findings Represent First Time Oral Therapy Tested Head-to-Head Against Standard Therapy; Surprising Biomarker Results Study shows GE Healthcare's Visipaque Associated with Lower Incidence of Contrast-Induced Nephropathy and Cardiovascular Events in Patients with Chronic Kidney Disease Compared to Iopromide Transgene’s TG1042 meets primary end point in step one of cutaneous B-cell lymphoma Phase II trial

November 24

Bioniche Presents MCC Data at the SIU World Uro-Oncology Update in Santiago, Chile Final Data From Phase 1 Investigator-Sponsored Trial of Oncophage Cancer Vaccine in Glioma Presented ARIAD to Present Preclinical Data on Multi-Targeted Kinase Inhibitor at 50th Ash Annual Meeting Third Pivotal Phase 3 Study for NicOx' Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal Virus Infections Valeant Reports Encouraging End of Treatment Results with Taribavirin at Treatment Week 48 in Phase IIb Study ProtoKinetix Receives Independent Confirmation of AAGP Anti-Inflammatory Action Largest-ever studies on most common form of adult leukemia, show patients treated with MabThera live longer without disease progressing Testosterone Effective in Female Sexual Dysfunction; BioSante Conducting Long-Term Safety Study of LibiGel in FSD Peregrine's Anti-Viral Bavituximab in Nature Medicine Avastin Plus Commonly Used Chemotherapies Demonstrated Improved Progression-Free Survival in Advanced Breast Cancer New Cancer Treatment Shrinks Pancreatic Tumor Schering-Plough Reports Preladenant Meets Primary Endpoint in Phase II Dose-Finding Trial for Parkinson's Disease Labopharm to Host Webcast Presentation on Novel Trazodone Formulation for Treatment of Major Depressive Disorder Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C Schering-Plough Unveils Top-Line Study Results for SAPHRIS (asenapine) Demonstrating Efficacy in Long-Term Schizophrenia Relapse Prevention Protox announces positive Phase 2 BPH results

Clinical Trial Results Archive

2005

April

More News Resources

(web2)